- New Study Explores Best Treatment for Recently Diagnosed RA Start with multiple meds or increase as needed? The TEAR study offers some answers 5/23/12
- FDA Advisory Panel Recommends Approval of New RA Drug Tofacitinib is part of an up-and-coming new class of disease-modifying drugs called JAK inhibitors 5/10/12
- Obesity May Be a Risk Factor for Developing RA Being obese could increase the risk of developing rheumatoid arthritis by 20 percent 5/9/12

























